Quigley Company, Inc.
Case Number:
1:04-bk-15739
Court:
Nature of Suit:
Firms
- Akerman LLP
- Blank Rome
- Brown Rudnick
- Caplin & Drysdale
- Cascino Vaughan
- CM Law PLLC
- Dal Lago Law
- Dechert LLP
- DLA Piper
- Dorsey & Whitney
- Douglas T. Tabachnik PC
- Edgar Snyder & Associates
- Emmet Marvin
- Farrell Fritz
- Foreman Law PLLC
- Fried Frank
- Friedman Kaplan
- Gibson Dunn
- Goldberg Persky
- Goodwin Procter
- Gordon Rees Scully Mansukhani
- Greenbaum Rowe
- Halperin Battaglia
- Haynes Boone
- Keating Muething
- Kelley & Ferraro
- Kriss & Feuerstein
- Levin & Glasser
- Lowenstein Sandler
- Lowey Dannenberg
- Meagher & Geer
- Melito & Adolfsen
- Mendes & Mount
- Milber Makris
- Motley Rice
- Schulte Roth
- Seyfarth Shaw
- Sheppard Mullin
- Skadden Arps
- Stevens & Lee
- Stutman Treister
- Stutzman Bromberg
- Thompson Hine
- Togut Segal
- Waters Kraus
- White and Williams
- Wiggin & Dana
- Wilentz Goldman
- Wilk Auslander
- WilmerHale
- Wilson Elser
- Windels Marx
- Zeichner Ellman
- Zirinsky Law Partners PLLC
Companies
- Allianz SE
- Armour Group Holdings Ltd.
- Arrowpoint Capital
- AXA SA
- CNA Financial Corp.
- Everest Group Ltd.
- Mintz Group Inc.
- O-I Glass Inc.
- Pfizer Inc.
- Quigley Company Inc.
- Safety National Casualty Corp.
- Wells Fargo & Co.
Sectors & Industries:
-
October 28, 2013
Schulte Scores $21M Payday For Quigley Bankruptcy Work
Schulte Roth & Zabel LLP on Friday received court approval for the $21 million in fees it sought for its work on Pfizer Inc. unit Quigley Co.'s nine-year bankruptcy proceeding.
-
June 26, 2013
Pfizer To Pay $964M In Quigley's Approved Ch. 11 Plan
A Manhattan federal judge Wednesday approved a Chapter 11 plan from Pfizer Inc.'s defunct Quigley Co. unit, which will cost the pharmaceutical giant $964 million and is designed to resolve the company's multibillion-dollar asbestos liability.
-
June 14, 2013
Nearly All Asbestos Claimants Back New Quigley Ch. 11 Plan
Pfizer Inc.'s bankrupt unit Quigley Co. Inc. on Thursday submitted its fifth amended reorganization plan that will pay asbestos claimants in cash, rights to insurance proceeds and common stock, but a small group of claimants still argue that the plan is unbalanced.
-
May 15, 2013
Dissident Quigley Creditors Now Support Ch. 11 Plan
Defunct Pfizer Inc. unit Quigley Co. Inc. now has a clearer path to exiting its eight-year bankruptcy after a holdout group of creditors moved Monday to reverse their votes and support the reorganization plan designed to resolve the company's multibillion-dollar asbestos liability.
-
February 26, 2013
Quigley To Make Another Bid For Plan Confirmation In June
Pfizer Inc. unit Quigley Co. Inc. on Tuesday set a June 26 confirmation hearing for its fifth amended Chapter 11 reorganization plan, almost nine years after the pharmaceutical giant entered bankruptcy.
-
November 06, 2012
Citing Sandy, Quigley Seeks More Voting Time For Ch. 11 Plan
Pfizer Inc. unit Quigley Co. Inc. asked a New York bankruptcy judge Monday to extend the voting deadline on its Chapter 11 plan by two weeks, saying Hurricane Sandy's aftermath has disadvantaged creditors in the Northeast, who have requested more time.
-
August 15, 2012
Quigley Ch. 11 Plan Heads To Vote Despite Protests
A New York bankruptcy judge approved Pfizer Inc. unit Quigley Co. Inc.'s disclosure statement Wednesday over objections by the U.S. trustee and two law firms representing asbestos claimants, on the condition that it be changed to reflect their discontent with its classification of settlement participants.
-
August 14, 2012
Quigley, Pfizer Answer Disclosure Statement Objections
Quigley Co. Inc. and parent Pfizer Inc. responded Monday in New York to objections by the U.S. trustee and others to Quigley's proposed disclosure statement, saying the Chapter 11 plan it describes clears up every issue the court named in rejecting an earlier version.
-
August 09, 2012
US Trustee Rips Pfizer Unit Quigley's Newest Ch. 11 Plan
A U.S. trustee on Wednesday knocked the latest disclosure statement from bankrupt Quigley Co. Inc., saying the Pfizer Inc. subsidiary had failed to explain how its recently proposed Chapter 11 reorganization differed from the plan the New York court refused to confirm two years earlier.
-
June 05, 2012
Pfizer Boosts Quigley Asbestos Funds In New Ch. 11 Plan
Pfizer Inc. unit Quigley Co. unveiled a new reorganization plan Monday that would increase Pfizer's payments toward an asbestos claims trust, responding to a New York bankruptcy judge's criticism of the drug giant's limited role in a previous plan.